{
    "info": {
        "nct_id": "NCT06191744",
        "official_title": "A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) Compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma (EPCOREâ„¢FL-2)",
        "inclusion_criteria": "* Diagnosis of follicular lymphoma (FL).\n* Have CD20+, histologically confirmed classic FL (previously Grade 1 to 3a FL) at most recent representative tumor biopsy based on the local pathology report, according to the 5th edition of World Health Organization (WHO) Classification of Haematolymphoid Tumours.\n* Are willing and able to comply with procedures required in the protocol.\n* Must have stage, III, IV or II with bulky disease >= 7cm).\n* Must be in need of systemic treatment per investigator, as evidenced by meeting at least one of the Groupe d'Etude des Lymphomes Folliculaire (GELF) criteria.\n* Has one or more target lesions:\n\n  * A positron emission tomography (PET)/computerized tomography (CT) scan demonstrating PET-positive lesion(s), and\n  * >=1 measurable nodal lesion (long axis >1.5cm) or >=1 measurable extra-nodal lesion (long axis >1.0 cm) on CT scan or MRI\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-2.\n* Able to receive at least one of the standard of care chemoimmunotherapy (CIT) treatment regimens: [Arm B] at the discretion of the Investigator, and rituximab and lenalidomide (R2) [Arm C].\n* Have laboratory values meeting the criteria in the protocol.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Had major surgery within 4 weeks prior to randomization.\n* Have active cytomegalovirus (CMV) disease.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Has one or more target lesions:",
            "criterions": [
                {
                    "exact_snippets": "Has one or more target lesions",
                    "criterion": "target lesions",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lesions"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have laboratory values meeting the criteria in the protocol.",
            "criterions": [
                {
                    "exact_snippets": "laboratory values meeting the criteria in the protocol",
                    "criterion": "laboratory values",
                    "requirements": [
                        {
                            "requirement_type": "meets protocol criteria",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A positron emission tomography (PET)/computerized tomography (CT) scan demonstrating PET-positive lesion(s), and",
            "criterions": [
                {
                    "exact_snippets": "A positron emission tomography (PET)/computerized tomography (CT) scan demonstrating PET-positive lesion(s)",
                    "criterion": "PET/CT scan",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "PET-positive lesion(s)",
                    "criterion": "PET-positive lesion(s)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) performance status 0-2.",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0-2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis of follicular lymphoma (FL).",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of follicular lymphoma (FL)",
                    "criterion": "follicular lymphoma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Able to receive at least one of the standard of care chemoimmunotherapy (CIT) treatment regimens: [Arm B] at the discretion of the Investigator, and rituximab and lenalidomide (R2) [Arm C].",
            "criterions": [
                {
                    "exact_snippets": "Able to receive at least one of the standard of care chemoimmunotherapy (CIT) treatment regimens",
                    "criterion": "ability to receive standard of care chemoimmunotherapy (CIT) treatment regimens",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "[Arm B] at the discretion of the Investigator",
                    "criterion": "eligibility for Arm B (CIT regimen)",
                    "requirements": [
                        {
                            "requirement_type": "investigator discretion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "rituximab and lenalidomide (R2) [Arm C]",
                    "criterion": "eligibility for Arm C (rituximab and lenalidomide, R2)",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have CD20+, histologically confirmed classic FL (previously Grade 1 to 3a FL) at most recent representative tumor biopsy based on the local pathology report, according to the 5th edition of World Health Organization (WHO) Classification of Haematolymphoid Tumours.",
            "criterions": [
                {
                    "exact_snippets": "CD20+",
                    "criterion": "CD20 expression",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "histologically confirmed classic FL (previously Grade 1 to 3a FL) at most recent representative tumor biopsy",
                    "criterion": "classic follicular lymphoma (FL) diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "grade",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": ""
                                    }
                                ]
                            }
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": "most recent representative tumor biopsy"
                        }
                    ]
                },
                {
                    "exact_snippets": "based on the local pathology report, according to the 5th edition of World Health Organization (WHO) Classification of Haematolymphoid Tumours",
                    "criterion": "diagnostic criteria source",
                    "requirements": [
                        {
                            "requirement_type": "classification system",
                            "expected_value": "5th edition of WHO Classification of Haematolymphoid Tumours"
                        },
                        {
                            "requirement_type": "pathology report source",
                            "expected_value": "local pathology report"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Are willing and able to comply with procedures required in the protocol.",
            "criterions": [
                {
                    "exact_snippets": "willing and able to comply with procedures required in the protocol",
                    "criterion": "compliance with protocol procedures",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* >=1 measurable nodal lesion (long axis >1.5cm) or >=1 measurable extra-nodal lesion (long axis >1.0 cm) on CT scan or MRI",
            "criterions": [
                {
                    "exact_snippets": ">=1 measurable nodal lesion (long axis >1.5cm)",
                    "criterion": "measurable nodal lesion",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lesion"
                            }
                        },
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">",
                                "value": 1.5,
                                "unit": "cm"
                            }
                        },
                        {
                            "requirement_type": "location",
                            "expected_value": "nodal"
                        }
                    ]
                },
                {
                    "exact_snippets": ">=1 measurable extra-nodal lesion (long axis >1.0 cm)",
                    "criterion": "measurable extra-nodal lesion",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lesion"
                            }
                        },
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">",
                                "value": 1.0,
                                "unit": "cm"
                            }
                        },
                        {
                            "requirement_type": "location",
                            "expected_value": "extra-nodal"
                        }
                    ]
                },
                {
                    "exact_snippets": "on CT scan or MRI",
                    "criterion": "imaging modality",
                    "requirements": [
                        {
                            "requirement_type": "modality",
                            "expected_value": [
                                "CT scan",
                                "MRI"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must be in need of systemic treatment per investigator, as evidenced by meeting at least one of the Groupe d'Etude des Lymphomes Folliculaire (GELF) criteria.",
            "criterions": [
                {
                    "exact_snippets": "Must be in need of systemic treatment per investigator",
                    "criterion": "need for systemic treatment",
                    "requirements": [
                        {
                            "requirement_type": "necessity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "as evidenced by meeting at least one of the Groupe d'Etude des Lymphomes Folliculaire (GELF) criteria",
                    "criterion": "GELF criteria",
                    "requirements": [
                        {
                            "requirement_type": "meets at least one criterion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must have stage, III, IV or II with bulky disease >= 7cm).",
            "criterions": [
                {
                    "exact_snippets": "stage, III, IV or II with bulky disease >= 7cm",
                    "criterion": "disease stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "III",
                                "IV"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "stage, ... II with bulky disease >= 7cm",
                    "criterion": "disease stage with bulky disease",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "II"
                        },
                        {
                            "requirement_type": "bulky disease size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 7,
                                "unit": "cm"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Had major surgery within 4 weeks prior to randomization.",
            "criterions": [
                {
                    "exact_snippets": "Had major surgery within 4 weeks prior to randomization.",
                    "criterion": "major surgery",
                    "requirements": [
                        {
                            "requirement_type": "time since surgery",
                            "expected_value": {
                                "operator": "<",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have active cytomegalovirus (CMV) disease.",
            "criterions": [
                {
                    "exact_snippets": "Have active cytomegalovirus (CMV) disease",
                    "criterion": "cytomegalovirus (CMV) disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}